2|0|Public
50|$|<b>Norpipanone</b> (INN, BAN; Hexalgon) is an opioid {{analgesic}} related to methadone which {{was developed in}} Germany and distributed in Hungary, Argentina, and other countries. It had originally not been under international control but upon observation of case reports of addiction it was reviewed and shortly thereafter became a controlled substance. In the United States, it is a Schedule I controlled substance (ACSCN 9636, zero annual manufacturing quota as of 2014). The salts in use are the hydrobromide (free base conversion ratio 0.806) and hydrochloride (0.902).|$|E
50|$|R-4066 (Spirodone) {{is a drug}} {{which is}} an {{analogue}} of the opioid analgesic methadone, or more accurately <b>norpipanone,</b> where the metabolically labile dimethylamino group {{has been replaced by}} a piperidinospiro group. Developed by Janssen Pharmaceutica, it is around 212x more potent than methadone as an analgesic in animal tests, with an effective oral dosage of 0.07 mg/kg, but is shorter acting, with a duration of action of around 3 hours. If the ketone function is reduced and acetylated, the racemate 106 x methadone and has an analgesic duration of 20.5 hours compared to 8 hours for methadone.|$|E

